Experience of a Single Center in Treating Multiple Manifestations of Tuberous Sclerosis Complex with Everolimus

Purpose The aim of this study was to evaluate the efficacy and tolerability of everolimus, an oral mammalian target of rapamycin (mTOR) inhibitor, for the treatment of tuberous sclerosis complex (TSC) manifestations. Methods A retrospective analysis was conducted using an in-house research database...

Full description

Bibliographic Details
Main Authors: Hyunji Ahn, Mi-Sun Yum, Han Na Jang, Cheryn Song, Tae-Sung Ko
Format: Article
Language:English
Published: Korean Child Neurology Society 2019-12-01
Series:Annals of Child Neurology
Subjects:
Online Access:http://www.annchildneurol.org/upload/pdf/acn-2019-00206.pdf

Similar Items